Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024
Compare Balance Sheet Results of Shukra Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
43.79
68.74
-24.95
-36.30%
Share Warrants & Outstandings
Total Reserve
19.05
1,021.24
-1,002.19
-98.13%
Shareholder's Funds
62.84
1,164.08
-1,101.24
-94.60%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.11
22.54
-19.43
-86.20%
Secured Loans
1.64
3.21
-1.57
-48.91%
Unsecured Loans
1.48
19.33
-17.85
-92.34%
Deferred Tax Assets / Liabilities
3.41
-44.63
48.04
107.64%
Other Long Term Liabilities
0.13
7.72
-7.59
-98.32%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
11.37
-11.37
-100.00%
Total Non-Current Liabilities
6.65
-3.01
9.66
320.93%
Current Liabilities
Trade Payables
9.22
110.46
-101.24
-91.65%
Other Current Liabilities
4.27
89.44
-85.17
-95.23%
Short Term Borrowings
1.06
14.62
-13.56
-92.75%
Short Term Provisions
2.74
1.83
0.91
49.73%
Total Current Liabilities
17.28
216.35
-199.07
-92.01%
Total Liabilities
86.77
1,377.42
-1,290.65
-93.70%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
43.42
650.45
-607.03
-93.32%
Less: Accumulated Depreciation
24.03
380.94
-356.91
-93.69%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
19.40
269.52
-250.12
-92.80%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.95
0.00
1.95
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
231.80
-231.80
-100.00%
Long Term Loans & Advances
0.00
81.17
-81.17
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
21.34
583.69
-562.35
-96.34%
Current Assets Loans & Advances
Current Investments
0.00
39.37
-39.37
-100.00%
Inventories
9.95
107.25
-97.30
-90.72%
Sundry Debtors
8.77
160.23
-151.46
-94.53%
Cash and Bank
12.12
413.01
-400.89
-97.07%
Other Current Assets
20.17
37.02
-16.85
-45.52%
Short Term Loans and Advances
14.42
36.86
-22.44
-60.88%
Total Current Assets
65.43
793.73
-728.30
-91.76%
Net Current Assets (Including Current Investments)
48.14
577.38
-529.24
-91.66%
Total Current Assets Excluding Current Investments
65.43
754.37
-688.94
-91.33%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.77
1,377.42
-1,290.65
-93.70%
Contingent Liabilities
1.40
0.11
1.29
1,172.73%
Total Debt
4.18
37.16
-32.98
-88.75%
Book Value per share (adjusted)
1.44
158.56
-157.12
-99.09%
Annual - Borrowings
Borrowings 4.18 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 21.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 65.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024






